The Senate Finance Committee voted Wednesday nearly unanimously to pass legislation regulating pharmacy benefits managers, or PBMs, whom critics claim are the middlemen largely responsible for high prescription drug prices.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
